Alto Ingredients, Inc. ALTO

3.73 (0.01) (0.27%) as of 25 Sep
Market cap
$290.1M
P/E
5.5×
Insider Buys alert about insiders buying in the last 12 month

Insider Decisions

Total buys 0.36
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — 1 — — 1 1
Sell — — — — — — — — — — — —
Insider Ownership 9.63%

Capital & Financial Ratios

Market Cap 290.11
Revenue 943.33
Net Income 51.99
Free Cash Flow 49.94
Net Debt 32.33
Current Ratio 3.19
Debt/Equity 0.23
P/E ratio 5.49
P/S ratio 0.30
P/B ratio 1.08
Past 5Y EPS Growth 15.50%
This Y EPS Growth 137.50%
Next Y EPS Growth (13.16%)
Next 5Y EPS Growth 20.00%
in millions of $

Dividends

Payout Ratio 0.00
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
2017 Powerpack
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 48 40 26 28
Receivables 59 58 55 68
Inventory 53 50 62 52
Other 10 5 13 13
169 153 156 161
2023 2024 2025 Q'26
Payables 21 20 15 24
ST’ Debt — — 17 —
Other 20 8 6 5
65 58 59 50
in millions of $

Compound Annual Growth

10y 5y 3y
Sales (2.57%) 0.46% (11.75%)
Cash Flow 0.00% (28.66%) 29.85%
Earnings 0.00% 0.00% 0.00%
Book Value (4.07%) (3.71%) (7.32%)

Revenue

Mar Jun Sep Dec Year
’26 225 246 — — —
’25 227 218 241 232 918
’24 241 236 252 236 965
’23 314 317 318 274 1,223
’22 308 362 337 328 1,336
’21 219 298 306 385 1,208
’20 311 212 205 169 897
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Mar Jun Sep Dec Year
’26 4 28 — — —
’25 (18) (1) 23 10 13
’24 1 (14) 19 (10) (4)
’23 (23) 10 23 12 22
’22 11 10 (19) 4 6
’21 (4) 8 (24) 46 27
’20 27 19 30 (4) 72
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Mar Jun Sep Dec Year
’26 3 18 — — —
’25 (19) (1) 21 8 9
’24 (3) (18) 18 (11) (14)
’23 (33) 2 16 7 (8)
’22 9 2 (34) (8) (32)
’21 (9) 9 (12) 23 10
’20 26 17 28 4 75
in millions of $ · fiscal quarters ending in the months shown

EPS

Mar Jun Sep Dec Year
’26 0.05 0.15 — — —
’25 (0.16) (0.15) 0.19 0.28 0.16
’24 (0.17) (0.05) (0.04) (0.57) (0.82)
’23 (0.18) 0.10 (0.05) (0.26) (0.40)
’22 (0.04) 0.29 (0.39) (0.46) (0.60)
’21 0.06 0.11 (0.05) 0.49 0.61
’20 (0.47) 0.27 0.24 (0.30) (0.28)
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
2.41 4.10 0.76 0.39 0.22 4.39 2.61 1.20 1.18 0.76

Analyst estimates 2026–2028

Powerpack
Low Price
10.95 10.05 4.75 1.67 11.44 8.34 7.37 4.97 2.80 3.18
High Price
500 560 510 500 370 417 439 460 393 390
Employees
3 3 3 3 2 3 3 3 2 2
Revenue/Emp
1,625 1,632 1,515 1,425 897 1,208 1,336 1,223 965 918
Revenue
3.35% 0.36% (1.00%) (0.70%) 5.89% 5.61% (2.06%) 1.28% 1.01% 3.80%
Gross Margin
1 (38) (68) (101) (17) 48 (40) (28) (59) 13
EBT
0.03% (2.35%) (4.52%) (7.11%) (1.93%) 3.94% (2.97%) (2.28%) (6.09%) 1.39%
EBT Margin
2 (38) (68) (101) (17) 46 (42) (28) (59) 13
Net Income
38 40 42 49 31 24 25 25 26 27
Depreciation
38.52 38.19 34.94 30.07 15.31 16.99 18.56 16.68 13.14 12.32
Revenue/Sh
0.00 (0.85) (1.42) (1.90) (0.28) 0.62 (0.60) (0.40) (0.82) 0.16
Earnings/Sh
0.88 0.85 0.04 (0.66) 1.22 0.38 0.08 0.30 (0.05) 0.18
Cash Flow/Sh
(0.45) (0.49) (0.35) (0.07) 0.06 (0.23) (0.52) (0.40) (0.15) (0.06)
Capex/Sh
0.43 0.37 (0.31) (0.73) 1.28 0.15 (0.44) (0.10) (0.19) 0.12
Free CF/Sh
9.92 8.98 7.36 4.79 5.05 4.86 4.28 3.81 3.06 3.29
Book Value/Sh
42 43 43 47 59 71 72 73 73 75
Shares
0.00 0.00 0.00 0.00 0.00 7.76 0.00 0.00 0.00 16.94
PE Ratio
0.26 0.12 0.02 0.02 0.35 0.28 0.16 0.16 0.12 0.23
PS Ratio
0.99 0.51 0.12 0.14 1.07 0.99 0.68 0.70 0.51 0.88
PB Ratio
0.34 0.24 0.16 0.18 0.41 0.26 0.17 0.19 0.18 0.29
EV/Sales
30.48 24.83 (17.82) (7.41) 4.89 30.50 (7.16) (31.28) (12.13) 30.99
EV/FCF
37 37 2 (31) 72 27 6 22 (4) 13
Op' Cash Flow
(19) (21) (15) (3) 3 (16) (38) (30) (11) (5)
Capex
18 16 (14) (35) 75 10 (32) (8) (14) 9
FCF
156 113 (63) 72 127 160 121 103 95 97
Working Cap'
199 241 231 244 97 54 72 82 93 80
Total Debt
135 192 205 225 49 (24) 18 34 53 53
Net Debt
418 384 319 227 296 345 308 280 225 245
Sh' Equity
0.02% (5.07%) (8.92%) (14.18%) (3.01%) 9.19% (8.90%) (6.28%) (14.08%) 3.06%
ROA
2.66% (2.78%) (6.15%) (10.33%) 1.78% 7.79% (11.77%) (4.75%) (11.60%) 1.54%
ROIC
0.04% (9.04%) (17.51%) (33.02%) (6.26%) 13.79% (13.12%) (9.96%) (23.88%) 5.13%
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Alto Ingredients, Inc. peers in Specialty Chemicals

Company Market cap P/E Compare
OEC Orion S.A. $340.3M 0.0× Compare
GEVO Gevo, Inc. $348.6M 0.0× Compare
FF FutureFuel Corp. $225.5M 0.0× Compare
HDSN Hudson Technologies, Inc. $220.1M 24.8× Compare
Company Market cap P/E Compare
MNTK Montauk Renewables, Inc. $409.9M 47.6× Compare
CMT Core Molding Technologies Inc $204.4M 27.0× Compare
AMTX Aemetis, Inc $129.9M 0.0× Compare
MATV Mativ Holdings, Inc. $671.7M 7.4× Compare

All 60 Specialty Chemicals stocks →

Alto Ingredients, Inc. (ALTO) key facts

  • Alto Ingredients, Inc. (ALTO) is a Specialty Chemicals company in the Basic Materials sector, listed on Nasdaq.
  • Alto Ingredients, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $917.9 million, down 4.90% from fiscal 2024.
  • Net income was $13.3 million, or $0.16 per share (basic), a net margin of 1.32%.
  • As of September 25, 2026, ALTO traded at $3.73, a market capitalization of $290.1 million.
  • At that price the stock trades at 5.5× trailing-twelve-month earnings and 0.3× sales.
  • Return on equity was 5.13% and debt-to-equity 0.23.

Source: company filings (standardised) and stockrow calculations.

Alto Ingredients, Inc. (ALTO) Latest News

News by impact score

Fine-tune

24 Aug

3

Alto Ingredients questions ability to hold recent stock gains as alcohol product premiums narrow and pressure margins. Narrowing alcohol premiums may moderately affect Alto Ingredients margins and market trajectory.

17 Aug

3

Alto Ingredients faces export challenges that may weigh on its growth outlook. Export challenges may moderately affect Alto Ingredients' financial performance and market position.

14 Aug

3

Alto Ingredients reports Q2 earnings, prompting analysis on buy, hold or sell decisions for ALTO stock based on results and outlook. Q2 earnings release may affect near-term stock movement without shifting long-term trajectory.

13 Aug

3 transcript

Alto Ingredients Inc. held its Q2 2026 earnings call, covering financial results, operational updates and forward outlook for the company. Quarterly earnings call provides performance data and guidance that can shift near-term investor views without altering long-term strategy.

11 Aug

3

45Z tax credits may serve as next earnings driver for Alto Ingredients, Inc. Potential 45Z tax credits could moderately influence Alto Ingredients earnings without fundamentally shifting long-term trajectory.

6 Aug

4

Alto Ingredients posted a sharp Q2 EBITDA increase that signals a potential company turnaround. Q2 EBITDA surge points to improved financial trajectory and investor sentiment for ALTO.

3

Alto Ingredients Q2 earnings call noted margin recovery progress and prioritized strategic focus on 45Z initiatives. Q2 margin recovery and 45Z focus signal moderately positive effects on near-term financials and positioning.

5 Aug

3

Alto Ingredients (ALTO) posted Q2 earnings and revenues above analyst estimates. Quarterly earnings beat signals improved financial results without shifting long-term company trajectory.

3 transcript

Alto Ingredients Q2 earnings call covered financial results, operational updates and forward guidance for the company. Earnings call data typically shifts short-term market views via fresh financial metrics and outlook statements.

3

Alto Ingredients, Inc. reported its second quarter 2026 financial results. Quarterly earnings releases disclose financial metrics that influence valuation and market perception.

27 Jul

4

Alto Ingredients plans to monetize every ton of biogenic CO2 through capture, utilization and sales initiatives tied to its existing production operations. Monetization of biogenic CO2 constitutes a major strategic move that can materially improve revenue and competitive positioning.

20 Jul

4

Potential E15 adoption could unlock next growth phase for Alto Ingredients through higher ethanol demand. E15 adoption represents regulatory shift that could significantly boost Alto Ingredients ethanol sales.

16 Jul

3

ALTO trades at a discount despite 344% rally over the past year, raising questions on next price trajectory and valuation. Stock valuation discussion can shift near-term sentiment but does not alter core operations or fundamentals.

13 Jul

3

Alto Ingredients considers debottlenecking to launch its next growth phase. Debottlenecking offers operational gains that may moderately lift efficiency and growth outlook.

10 Jul

3

Alto Ingredients (ALTO) added to Russell indices while pursuing river logistics expansion, increasing index fund exposure and aiming to strengthen operational logistics for potential shareholder gains. Russell index additions increase passive investment flows while river logistics bet targets supply chain gains without altering core trajectory.

9 Jul

3

Alto Ingredients (ALTO) stock could be 35% undervalued following Russell Index inclusion. Russell Index inclusion typically draws institutional buying that can lift valuation and short-term trading volume for ALTO.

6 Jul

3

Alto Ingredients returned to profitability but questions remain on sustaining momentum amid ongoing market and operational pressures. Discussion of profitability sustainability may moderately affect investor sentiment toward ALTO shares.

2 Jul

4

Alto Ingredients is expanding production capacity at its Pekin facility. Pekin capacity expansion is a major strategic investment that can significantly increase output and improve market position.

29 Jun

4

Alto Ingredients considers biogenic CO2 capture and sales as potential new growth business alongside existing ethanol operations. Biogenic CO2 development represents major strategic expansion opportunity that could alter Alto Ingredients revenue trajectory.

3

Alto Ingredients, Inc. (ALTO) added to Russell 2000® and Russell 3000® Indexes. Index inclusion draws passive fund inflows and lifts trading liquidity without altering core operations.

26 Jun

3

H.C. Wainwright raised its price target on Alto Ingredients (ALTO) after the company returned to profitability. Analyst price target increase following profitability signals moderate positive sentiment shift without major operational changes.

22 Jun

3

Alto Ingredients earns more from each bushel of corn due to improved operational efficiencies. Higher earnings per bushel signal operational gains with moderate effects on financial results.

18 Jun

4

Alto Ingredients receives cash inflow from 45Z tax credit, indicating its stock could be 45% undervalued. 45Z tax credit cash inflow boosts ALTO financials and supports major upward revaluation of its shares.

16 Jun

3

Alto Ingredients (ALTO) shares rose 5.3% after monetizing 2025 clean fuel tax credits for cash. Immediate cash from future tax credits improves near-term liquidity without altering core long-term trajectory.

3

Alto Ingredients, Inc. (ALTO) stock has risen 374% over the past year. A 374% annual stock rise indicates strong recent performance with moderate ongoing influence on future sentiment and trading activity.

15 Jun

4

Alto Ingredients completed a transaction monetizing all 2025 45Z clean fuel production tax credits. Monetizing 2025 tax credits delivers substantial immediate cash flow to Alto Ingredients.

3

Alto Ingredients is accessing 45Z tax credits with the size of the resulting opportunity still undetermined. 45Z credit access can improve near-term cash flow but does not yet indicate a fundamental shift in operations or market position.

8 Jun

3

Strong export demand boosted Alto Ingredients' profitability. Export demand gains directly lifted revenue and margins for the company's core operations.

2 Jun

3

Alto Ingredients benefits from stronger returns in its essential ingredients segment, supporting improved financial results and operational performance. Stronger essential ingredients returns improve Alto Ingredients financial performance and market position.

11 May

4

Alto Ingredients (ALTO) upgraded to Strong Buy by analysts due to favorable factors outlined in the report. Analyst upgrade to Strong Buy enhances investor sentiment and could significantly boost stock performance.

stockrow.com/ALTO · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com